Advancements in Robotic Surgery at Hospital Da Luz
In exciting news from Lisbon, Portugal, Hospital da Luz has made history by becoming the first institution in the country to implement the Genesis Robotic Magnetic Navigation (RMN) System. This system promises to revolutionize how complex heart conditions are diagnosed and treated, further establishing the hospital’s reputation as a leader in cardiac healthcare.
Prof. Pedro Adragão's Enthusiasm for Innovation
Prof. Pedro Adragão, a prominent cardiac electrophysiologist at Hospital da Luz, expressed great enthusiasm about the introduction of the Genesis System. He noted, “We are thrilled to leverage this cutting-edge technology to enhance patient care. The robotic system enables us to provide tailored therapies focused on safety, ensuring that even patients with the most complex arrhythmias receive the best possible care.” His commitment to combining high-tech solutions with patient-centric methodology sets a remarkable standard for cardiac treatment.
Hospital da Luz and its Pioneering Role
Hospital da Luz, part of the Luz Saúde group, which is the largest healthcare network in Portugal, has achieved incredible milestones, having conducted over 4,000 robotic cardiac ablation procedures. By integrating the Genesis System into their facilities, the hospital continues to pave the way for advances in robotic surgery. The advantages of Robotic Magnetic Navigation technology notably include enhanced precision during procedures and increased safety, factors that are crucial in treating arrhythmias—a condition that affects millions globally. Untreated arrhythmias can lead to serious health risks such as stroke and heart failure.
The Vision of Stereotaxis
David Fischel, Chairman and CEO of Stereotaxis, expressed his satisfaction with this collaboration, stating, “We are eager to support Hospital da Luz in its commitment to improving patient outcomes through groundbreaking technologies. Partnerships like this not only advance clinical practices but also foster innovation in robotic healthcare.” Stereotaxis, known for its pioneering contributions to surgical robotics, aims to enhance both the safety and effectiveness of minimally invasive procedures.
About Stereotaxis
Stereotaxis (NYSE: STXS) stands out as a leader in innovative surgical robotics, focusing on creating systems that facilitate minimally invasive endovascular interventions. Their core mission revolves around the development of robotic systems, tools, and technological solutions designed to empower physicians to deliver precise and safe treatments. More than 150,000 patients have benefitted from Stereotaxis technology across various continents, highlighting its global impact on healthcare.
Frequently Asked Questions
What is the Genesis Robotic Magnetic Navigation System?
The Genesis System is an advanced robotic platform that facilitates precise navigation during cardiac procedures, improving patient outcomes and safety.
Why is the implementation of this technology significant?
This technology enables safer, more effective treatment methods for complex heart conditions, particularly arrhythmias that can lead to severe health risks if untreated.
Who expressed support for the new technology at Hospital da Luz?
Prof. Pedro Adragão, along with David Fischel of Stereotaxis, expressed keen support for the integration of the Genesis System at Hospital da Luz, indicating its positive potential for patient care.
How does Hospital da Luz contribute to cardiac healthcare in Portugal?
As a leading university hospital, Hospital da Luz has performed thousands of robotic cardiac procedures and consistently invests in advanced medical technologies to enhance patient care.
What is Stereotaxis known for?
Stereotaxis is recognized as a pioneer in the field of surgical robotics, developing innovative tools that promote safer and more efficient surgeries in the interventional laboratory.
